Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factorial randomized trial of bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibition and TAXUS vs bare-metal stent in ST-elevation myocardial infarction
2005-001514-41Phase 3Completed
- Sponsor
- Cardiovascular Research Foundation
- Start
- Jun 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bivalirudin, heparin and paclitaxel in myocardial infarction (MI) (4 arms), sponsored by Cardiovascular Research Foundation. Started Jun 2005; status: completed.
02
Drugs
bivalirudinheparinpaclitaxel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2005-001514-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001514-41.